期刊文献+

1例亚胺培南西司他丁钠引发药物热的诊断 被引量:1

Diagnosis of the Drug Fever Caused by Imipenem/Cilastatin
下载PDF
导出
摘要 目的探讨药物热的发病机制、临床特点及诊疗要点,以提高临床医生和临床药师对药物热的早期识别,减轻患者痛苦,降低医院费用。方法对1例肾结石激光碎石术后持续发热的病例诊疗进行分析。结果患者术后感染性休克,予亚胺培南西司他丁钠0. 5 g q6h抗感染8 d,体温好转,3 d后体温再次升高,加强抗感染治疗无效,停用所有抗菌药后体温正常,证实为亚胺培南西司他丁钠所致药物热。结论药物热机制复杂,临床表现多样。临床医生及临床药师加强对药物热的早期识别,有助于减轻患者痛苦,降低医疗成本。 Ojbective To explore the pathogenesis,clinical features and diagnosis and treatment of drug fever,to improve the early identification of drug fever by clinicians and clinical pharmacists,reduce patient suffering and reduce hospital costs.Methods One case of diagnosis and treatment of persistent fever after renal lithotripsy laser lithotripsy was analyzed.Results After septic shock,imipenem/cilastatin0.5g q6h was anti-infected for8days,the body temperature improved,and the body temperature increased again after3days.The anti-infective treatment was ineffective,and the body temperature was normal after all antibiotics were stopped.It was confirmed to be the drug fever caused by imipenem/cilastatin.Conclusion The drug thermal mechanism is complex and the clinical manifestations are diverse.Clinicians and clinical pharmacists enhance early identification of drug heat,helping to alleviate patient suffering and reduce medical costs.
作者 宋小玲 刘小英 江媛璎 钟海利 SONG Xiaoling;LIU Xiaoying;JIANG Yuanying;ZHONG Haili(The First Affiliated Hospital of Nanchang University,Nanchang 330006,China)
出处 《现代医院》 2018年第12期1856-1858,共3页 Modern Hospitals
关键词 亚胺培南西司他丁钠 药物热 诊断 临床药师 Imipenem/Cilastatin Drug Fever Diagnosis Clinical Pharmacists
  • 相关文献

参考文献7

二级参考文献75

  • 1刘华生.β-内酰胺类抗生素所致药物热分析[J].中国基层医药,2004,11(9):1124-1124. 被引量:11
  • 2杜文民,王永铭,程能能.药品不良反应的判定与其研究方法(续完)[J].中国药物警戒,2005,2(1):11-13. 被引量:27
  • 3赵丽,王世栋,赵敏.β-内酰胺类抗生素致药物热11例临床分析[J].大连医科大学学报,2005,27(4):303-304. 被引量:3
  • 4梁国庆,谢仲豪.抗生素致药物热18例[J].实用医学杂志,2007,23(4):460-460. 被引量:5
  • 5Emanueli A, Sacchetti G. An algorithm for the classification of untoward events in large scale clinical trials[ J]. Agents Actions Suppl, 1980,7:318.
  • 6Venulet J, Ciucci A, Bemeker G C. Standardised assessment of drugZadverse reaction associations : rationale and experience [ J ]. Int J Clin Pharmacol Ther Toxicol, 1980,18 : 381.
  • 7Jones J K. Adverse drug reactions in the community health set- ting:approaches to recognizing, counseling, and reporting [ J] . Faro Community Health, 1982,5:58.
  • 8Wiholm B E. The Swedish drug-event assessment methods: spe- cial workshop-regulatory [ J ]. Drug Inf J, 1984,18:267.
  • 9Karch F E, Lasagna L Toward the operational identification of ad- verse drug reactions[ J]. Clin Pharmacol Ther,1977 ,21:247.
  • 10Naranjo C A, Busto U, Sellers E M, et al. A method for estimating the probability of adverse drug reactions [ J ] . Clin Pharmacol Tber,30(2) :239.

共引文献199

同被引文献75

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部